Meanwhile, there were twenty-eight CpG island sites in the CALCB promoter region, with a methylation percentage of 57.5% in pancreatic cancer (Figure 2(c)) and 11.4% in paracancer tissues (Figure 2(d)) determined by BSP. Here, CALCB is linked to pancreatic neoplasm.